Correlation Between Biofil Chemicals and Sonata Software

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Sonata Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Sonata Software into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Sonata Software Limited, you can compare the effects of market volatilities on Biofil Chemicals and Sonata Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Sonata Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Sonata Software.

Diversification Opportunities for Biofil Chemicals and Sonata Software

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biofil and Sonata is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Sonata Software Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonata Software and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Sonata Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonata Software has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Sonata Software go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Sonata Software

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 5.24 times less return on investment than Sonata Software. But when comparing it to its historical volatility, Biofil Chemicals Pharmaceuticals is 2.46 times less risky than Sonata Software. It trades about 0.02 of its potential returns per unit of risk. Sonata Software Limited is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  28,078  in Sonata Software Limited on September 3, 2024 and sell it today you would earn a total of  34,512  from holding Sonata Software Limited or generate 122.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biofil Chemicals Pharmaceutica  vs.  Sonata Software Limited

 Performance 
       Timeline  
Biofil Chemicals Pha 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Sonata Software 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonata Software Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Sonata Software is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Biofil Chemicals and Sonata Software Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofil Chemicals and Sonata Software

The main advantage of trading using opposite Biofil Chemicals and Sonata Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Sonata Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonata Software will offset losses from the drop in Sonata Software's long position.
The idea behind Biofil Chemicals Pharmaceuticals and Sonata Software Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins